Skingenix, Inc. announces completion of two pilot clinical studies with the investigational product in patients with Venous Leg Ulcers and Diabetic Foot Ulcers in USA.

Under an Investigational New Drug Application (IND), Skingenix has successfully  completed two pilot clinical studies in USA :

  1. First clinical study was conducted in patients with Venous Leg Ulcer.
  2. The second clinical study was conducted in patients with Diabetic Foot Ulcers.

These studies were completed in December 2011.